Livemedia Home
A+ | A-

 Login / Register to Livemedia


17/03/2016 Congresses | 8th Larissa International Congress of Internal Medicine

Congresses |  8th Larissa International Congress of Internal Medicine  
 

Share

183.128 total
8 live
51.357 video
127.031 photo
Views:
Watch on Demand the  8th Larissa International Congress of Internal Medicine, organized by:

Institute of Internal Medicine & Hepatology
Department of Medicine & Research Laboratory of Internal Medicine
University of Thessaly Medical School

In cooperation with:
Hellenic Association for the Study of the Liver
Hellenic Stroke Organization

Date March 17-19, 2016
Venue: Larissa Imperial Hotel, Larissa, Greece

Click here to view the eprogram and evaluate the sessions of the conference.

For more information, please click here.


 
Sort by Date | Views
17/03 Hall OLYMPOS
14:30 - 16:00
CARDIOVASCULAR MEDICINE CARDIOVASCULAR MEDICINE

OP01-OP09

Evaluated
Evaluation
14:30 - 14:40
OP01

ASTRAL PROGNOSTIC SCORE HAS A HIGH PROGNOSTIC ACCURACY IN BOTH THROMBOLYZED AND NONTHROMBOLYZED PATIENTS WITH ACUTE ISCHAEMIC STROKE

Evaluated
Evaluation

Speaker: Vasileios Papavasileiou

14:40 - 14:50
OP02

ASTRAL, DRAGON & SEDAN SCORES PREDICT STROKE OUTCOME MORE ACCURATELY THAN STROKE-TREATING PHYSICIANS

Evaluated
Evaluation

Speaker: Fotios Gioulekas

14:50 - 15:00
OP03

WHICH CVS RISK REDUCTION STRATEGY FITS BETTER TO CAROTID US FINDINGS?

Evaluated
Evaluation

Speaker: Stergios Soulaidopoulos

15:00 - 15:10
OP04

RISK STRATIFICATION FOR RECURRENCE AND MORTALITY IN EMBOLIC STROKE OF UNDETERMINED SOURCE

Evaluated
Evaluation

Speaker: George Athanasakis

15:10 - 15:20
OP05

PROTOCOL AND GUIDELINE COMPLIANCE IN STROKE MORTALITY: THE EXPERIENCE OF A COMPREHENSIVE STROKE CENTRE

Evaluated
Evaluation

Speaker: Vasileios Papavasileiou

15:20 - 15:30
OP06

PROGNOSTIC SIGNIFICANCE OF STRESS HYPERGLYCEMIA IN ACUTE ISCHEMIC STROKE

Evaluated
Evaluation

Speaker: Stella-Maria Angelopoulou

15:30 - 15:40
OP07

COGNITION AND NUTRITIONAL FACTORS IN PREDICTING POOR OUTCOMES IN GERIATRIC REHABILITATION

Evaluated
Evaluation

Speaker: Dwaipayan Sen

15:40 - 15:50
OP08

PLATELET-MEDIATED RELEASE OF NEUTROPHIL EXTRACELLULAR TRAPS LEADS TO THE EXPOSURE OF ACTIVE TISSUE FACTOR AT THE SITE OF PLAQUE RUPTURE DURING MYOCARDIAL INFARCTION

Evaluated
Evaluation

Speaker: Konstantinos Kambas

15:50 - 16:00
OP09

LIPID RED BLOOD CELL MEMBRANES FOLLOWS THE PROGRESSION OF ISCHEMIC HEART DISEASE: AN NMR-BASED STUDY

Evaluated
Evaluation

Speaker: Ioanna Kastani

Chairmen: Konstantinos Makaritsis (Larissa,Greece), Dwaipayan Sen (Manchester,UK)

16:00 - 16:30
STATE-OF-THE-ART LECTURE STATE-OF-THE-ART LECTURE

Hellenic Stroke Organization

Evaluated
Evaluation
16:00 - 16:30
Intracerebral haemorrhage: what is the cause?

Evaluated
Evaluation

Speaker: Charlotte Cordonnier (Lille, France)

Chairmαn: Konstantinos Fountas (Larissa, Greece)

16:30 - 17:00
Coffee Break 

17:00 - 17:30
SATELLITE LECTURE - Sponsored by Sanofi SATELLITE LECTURE

Defining the role of PCSK9 inhibitor alirocumab in the treatment of hyperlipidemia

Evaluated
Evaluation
17:30 - 19:00
ROUND TABLE 

Stroke in 2020

Evaluated
Evaluation
17:30 - 17:50
Patent foramen ovale:

closure or not?

Evaluated
Evaluation

Speaker: Roland Veltkamp (London, UK)

17:50 - 18:10
Organization of stroke care in the era of endovascular treatment

Evaluated
Evaluation

Speaker: Urs Fischer (Bern, Switzerland)

18:10 - 18:30
Direct oral anticoagulants for embolic strokes of undetermined source?

Evaluated
Evaluation

Speaker: George Ntaios (Larissa, Greece)

18:30 - 18:50
Proprotein convertase subtilisin/kexin type 9 inhibitors for stroke prevention?

Evaluated
Evaluation

Speaker: Eivind Berge (Oslo, Norway)

Chairmen: Charlotte Cordonnier (Lille, France), Konstantinos Vemmos (Athens, Greece)

19:30 - 20:00
STATE-OF-THE-ART LECTURE 

Evaluated
Evaluation
19:00 - 19:30
Conflicts of interest: how to handle them?

Evaluated
Evaluation

Speaker:  Bart Van Der Worp (Utrecht, The Netherlands)

Chairmαn: Eivind Berge (Oslo, Norway)

19:45 - 21:00
OPENING CEREMONY OPENING CEREMONY

Evaluated
Evaluation
21:00 - 21:15
Welcome

Evaluated
Evaluation
21:15 - 21:45
Inaugural Lecture

Too much or too little medicine

Evaluated
Evaluation

Speaker: Dimitrios Sideris (Athens, Greece)

18/03 Hall ACHILLEAS
08:00 - 09:30
HEPATOLOGY - GASTROENTEROLOGY - METABOLIC SYNDROME HEPATOLOGY - GASTROENTEROLOGY - METABOLIC SYNDROME

OP19-OP27

Evaluated
Evaluation
00:00 - 00:00
OP24

EXTRAINTESTINAL MANIFESTATIONS AT THE TIME OF DIAGNOSIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Evaluated
Evaluation
08:00 - 08:10
OP19

HIGH IL6 LEVELS ARE POSITIVELY CORRELATED WITH HIGH FREE CORTISOL LEVELS IN PATIENTS WITH ACUTE VARICEAL BLEEDING

Evaluated
Evaluation

Speaker: Maria Kalafateli

08:10 - 08:20
OP20

SPONTANEOUS BACTERIAL PERITONITIS IN PATIENTS WITH DECOMPENSATED CIRRHOSIS. MICROBIAL CAUSES AND CHARACTERISTICS

Evaluated
Evaluation

Speaker: A.M. Markantonatou

08:20 - 08:30
OP21

A NATURAL HISTORY STUDY OF DECOMPENSATED ALCOHOLIC CIRRHOSIS: RECENT IMPROVEMENT IN SURVIVAL

Evaluated
Evaluation

Speaker: Dimitrios N. Samonakis

08:30 - 08:40
OP22

TIPS FOR THE MANAGEMENT OF COMPLICATIONS OF LIVER CIRRHOSIS: A RETROSPECTIVE AUDIT

Evaluated
Evaluation

Speaker: Dimitrios N. Samonakis

08:40 - 08:50
OP23

BILLROTH II VERSUS BILLROTH II AND BRAUN

Evaluated
Evaluation

Speaker: Konstantinos Perivoliotis

08:50 - 09:00
OP24

EXTRAINTESTINAL MANIFESTATIONS AT THE TIME OF DIAGNOSIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Evaluated
Evaluation

Speaker: Georgios Ntetskas

09:00 - 09:10
OP25

INTESTINAL METAPLASIA IN PATIENTS WITH MULTIFOCAL ATROPHIC GASTRITIS

Evaluated
Evaluation

Speaker: Nikolaos Chrysanthos

09:10 - 09:20
OP26

METABOLIC PROFILE OF PATIENTS WITH SEVERE MENTAL DISORDERS IN AN INTERNAL MEDICINE CLINIC

Evaluated
Evaluation

Speaker: Petrou Danae

09:20 - 09:30
OP27

THE MEASUREMENT OF SERUM LEVEL OF IL-18 IN TYPE II DIABETIC PATIENTS SUFFERED FROM NEPHROPATHY IN ZAHEDAN CITY

Evaluated
Evaluation

Speaker: Hossein Ali Khazaei

Chairmen: Konstantinos Mimidis (Alexandroupolis, Greece), Dimitrios Samonakis (Heraklion, Greece)

18/03 Hall ALKISTIS - THETIDA
14:00 - 15:30
E-POSTER PRESENTATIONS CARDIOVASCULAR MEDICINE - METABOLIC SYNDROME

(Screen A) e-PP01 - e-PP13

Evaluated
Evaluation

Chairmen: Dimitrios Papazoglou (Alexandroupolis, Greece), Vasileios Tsimihodimos (Ioannina, Greece)

14:00 - 15:30
E-POSTER PRESENTATIONS HEPATOLOGY - GASTROENTEROLOGY

(Screen B) e-PP14-e-PP26

Evaluated
Evaluation

Chairmen: Melanie Deutsch (Athens, Greece), Grigorios Giannoulis (Athens, Greece)

18/03 Hall CHRISALIDA
14:00 - 15:30
E-POSTER PRESENTATIONS HEPATOLOGY - GASTROENTEROLOGY

(Screen C) e-PP27-e-PP39

Evaluated
Evaluation

Chairmen: Vasileios Sevastianos (Athens, Greece), Christos Triantos (Patras, Greece)

18/03 Hall NEFELI
14:00 - 15:30
E-POSTER PRESENTATIONS GERIATRIC MEDICINE - IMMUNOLOGY - RHEUMATOLOGY

(Screen D) e-PP40-e-PP52

Evaluated
Evaluation

Chairmen: Irene Rapti (Athens, Greece), Panagiotis Skendros (Alexandroupolis, Greece)

18/03 Hall OLYMPOS
08:00 - 09:30
HEPATOLOGY - GASTROENTEROLOGY HEPATOLOGY - GASTROENTEROLOGY

OP10-OP18

Evaluated
Evaluation
08:00 - 08:10
OP10

NUCLEOS(T)IDE ANALOGUE PROPHYLAXIS AFTER HEPATITIS B IMMUNOGLOBIN WITHDRAWL IS SAFE AND EFFECTIVE AGAINST HEPATITIS B AND D RECURRENCE AFTER LIVER TRANSPLANTATION

Evaluated
Evaluation

Speaker: Evangelos Cholongitas

08:10 - 08:20
OP11

URINE ALBUMIN-TO-CREATININE RATIO IS ASSOCIATED WITH THE SEVERITY OF LIVER DISEASE, RENAL FUNCTION AND SURVIVAL IN PATIENTS WITH DECOMPENSATED CIRRHOSIS

Evaluated
Evaluation

Speaker: Stergios Soulaidopoulos

08:20 - 08:30
OP12

ALLOPURINOL ABROGATES THIOPURINE INDUCED LIVER INJURY

Evaluated
Evaluation

Speaker: Polychronis Pavlidis

08:30 - 08:40
OP13

GEOEPIDEMIOLOGY OF PRIMARY BILIARY CIRRHOSIS IN CENTRAL GREECE

Evaluated
Evaluation

Speaker: K. Azariadis

08:40 - 08:50
OP14

HEPATIC STEATOSIS AND/OR STEATOHEPATITIS IN PRIMARY BILIARY CIRRHOSIS: AN INNOCENT BYSTANDER OR A GUILTY PLAYER?

Evaluated
Evaluation

Speaker: V. Lygoura

08:50 - 09:00
OP15

AUTOIMMUNE HEPATITIS (AIH): IMPACT OF AGE AT DISEASE ONSET ON DISEASE SEVERITY, OUTCOME AND RESPONSE TO TREATMENT

Evaluated
Evaluation

Speaker: K. Azariadis

09:00 - 09:10
OP16

PROMPT INITIATION OF INTRAVENOUS CORTICOSTEROIDS PREVENTS DETERIORATION OF ACUTE/SEVERE AUTOIMMUNE HEPATITIS (AS-AIH) AND THE NEED OF LIVER TRANSPLANTATION (LT)

Evaluated
Evaluation

Speaker: Pinelopi Arvaniti

09:10 - 09:20
OP17

Evaluated
Evaluation

Speaker: Polychronis Pavlidis

09:20 - 09:30
OP18

NEUTROPHIL EXTRACELLULAR TRAPS ARE SPATIALLY DISTRIBUTED IN COLON CANCER TISSUE AND MAY BE IMPLICATED IN TUMOUR GROWTH BY INDUCING CANCER CELL APOPTOSIS

Evaluated
Evaluation

Speaker: Athanasios Arampatzioglou

Chairmen: Evangelos Cholongitas (Thessaloniki, Greece), Stylianos Karatapanis (Rhodes, Greece)

09:30 - 10:30
SYMPOSIUM 

Prostate disease in 2016

Evaluated
Evaluation
09:30 - 10:00
Is there a link between benign prostate hyperplasia, prostate cancer and inflammation?

Evaluated
Evaluation

Speaker: Dionysios Mitropoulos (Athens, Greece)

10:00 - 10:30
Benign prostatic hyperplasia and metabolic syndrome

Evaluated
Evaluation

Speaker: Mauro Gacci (Florence, Italy)

Chairmαn: Stavros Gravas (Larissa, Greece)

10:30 - 11:00
Coffee Break 

11:00 - 13:00
ROUND TABLE Advances in therapeutic strategies for HBV and HCV

Advances in therapeutic strategies for HBV and HCV

Evaluated
Evaluation
11:00 - 11:24
Is HBsAg loss an achievable target for therapy?

Evaluated
Evaluation

Speaker: Spilios Manolakopoulos (Athens, Greece)

11:24 - 11:48
Difficult to treat patients with HBV infection

Evaluated
Evaluation

Speaker: George Papatheodoridis (Athens, Greece))

11:48 - 12:12
Current challenges in non-HCV-1 genotype therapy

Evaluated
Evaluation

Speaker: Markus Cornberg (Hannover, Germany)

12:12 - 12:36
Cost effectiveness, barriers and access to HCV treatment in Europe

Evaluated
Evaluation

Speaker: Maria Buti (Barcelona, Spain)

12:36 - 13:00
Future treatment options in failures to any antiviral therapy

Evaluated
Evaluation

Speaker: Rafael Esteban (Barcelona, Spain)

Chairmen: Rafael Esteban (Barcelona, Spain), George N. George N. (Larissa, Greece)

13:00 - 14:00
SATELLITE SYMPOSIUM - Sponsored by Abbvie Pharmaceuticals SA SATELLITE SYMPOSIUM

Chronic hepatitis C: managing “special” populations

Evaluated
Evaluation
15:30 - 16:00
Leisure time 

16:00 - 17:30
ROUND TABLE Resistant hypertension

Resistant hypertension

Evaluated
Evaluation
16:00 - 16:22
Diagnosis and evaluation

Evaluated
Evaluation

Speaker: Konstantinos Makaritsis (Larissa, Greece)

16:22 - 16:44
Medical management

Evaluated
Evaluation

Speaker: Michel Burnier (Lausanne, Switzerland)

16:44 - 17:06
New invasive treatment modalities

Evaluated
Evaluation

Speaker: Konstantinos Tsioufis (Athens, Greece)

17:06 - 17:30
Long term effects of invasive therapy - Hints for the future

Evaluated
Evaluation

Speaker: Roland Roland (Nuremberg, Germany)

Chairmen: Konstantinos Tsioufis (Athens, Greece), Dimitrios Vlahakos (Athens, Greece)

17:30 - 18:15
SATELLITE SYMPOSIUM - Sponsored by Astellas SATELLITE SYMPOSIUM

The role of echinocandins in clinical practice

Evaluated
Evaluation
18:15 - 18:45
Coffee Break 

18:45 - 20:15
ROUND TABLE 

Intestinal microbiota and metabolic disorders

Evaluated
Evaluation
18:45 - 19:15
Microbiota patterns and risk of glucometabolic disease

Evaluated
Evaluation

Speaker: Peter Nilsson (Malmo, Sweden)

19:15 - 19:45
Intestinal microbiota lipid metabolism and atherosclerosis

Evaluated
Evaluation

Speaker: Alexandros Tselepis (Ioannina, Greece)

19:45 - 20:15
Insights into the role of the microbiota in the natural history of obesity

Evaluated
Evaluation

Speaker: Dimitrios Papazoglou (Alexandroupolis, Greece)

Chairmen: Apostolos Hatzitolios (Thessaloniki, Greece), Alexandros Tselepis (Ioannina, Greece)

20:15 - 21:00
SATELLITE SYMPOSIUM - Sponsored by Winmedica SATELLITE SYMPOSIUM

Recent advances targeting cardiovascular risk reduction and treatment of symptomatic peripheral artery disease

Evaluated
Evaluation
19/03 Hall ACHILLEAS
07:45 - 09:00
GERIATRIC MEDICINE - INFECTIOUS DISEASES GERIATRIC MEDICINE - INFECTIOUS DISEASES

OP35-OP41

Evaluated
Evaluation
07:45 - 07:55
OP35

ADVERSE DRUG REACTIONS AS A CAUSE FOR HOSPITAL ADMISSION IN THE ELDERLY

Evaluated
Evaluation

Speaker: Panagiota Voukelatou

07:55 - 08:05
OP35

ADVERSE DRUG REACTIONS AS A CAUSE FOR HOSPITAL ADMISSION IN THE ELDERLY

Evaluated
Evaluation

Speaker: Panagiota Voukelatou

08:05 - 08:15
OP36

HIV INFECTION AND HYPERTENSION IN ATHEROSCLEROSIS

Evaluated
Evaluation

Speaker: Galaktion Konstantinidis

08:15 - 08:25
OP37

THE ISOLATION OF CANDIDA STRAINS IN BRONCHIAL SECRETIONS SELECTED FROM PATIENTS IN THE INTENSIVE CARE UNIT OF A GENERAL HOSPITAL LOCATED IN WESTERN GREECE

Evaluated
Evaluation

Speaker: Eirini Tatsina

08:25 - 08:35
OP38

A STUDY OF CASES OF BACTEREMIA DURING THE LAST FIVE YEARS IN A GENERAL HOSPITAL IN NORTH WESTERN GREECE

Evaluated
Evaluation

Speaker: Eirini Tatsina

08:35 - 08:45
OP39

RAPID DETECTION OF VANCOMYCIN-RESISTANT ENTEROCOCCI (VRE) CARRIERS IN A TERTIARY GREEK HOSPITAL

Evaluated
Evaluation

Speaker: Styliani Sarrou

08:45 - 08:55
OP40

MOLECULAR EPIDEMIOLOGY AND ANTIMICROBIAL SUSCEPTIBILITY OF CLOSTRIDIUM DIFFICILE ISOLATED FROM A UNIVERSITY TEACHING HOSPITAL IN GREECE

Evaluated
Evaluation

Speaker: Christina Chatedaki

08:55 - 09:00
OP41

AUTOCHTHONOUS PLASMODIUM VIVAX INFECTION IN LARISA: ΟNE OF SIX CASES IN OUR COUNTRY DURING 2015

Evaluated
Evaluation

Speaker: Kalliopi Azariadi

Chairmen: Efthimia Petinaki (Larissa, Greece), Christos Savopoulos (Thessaloniki, Greece)

19/03 Hall ALKISTIS - THETIDA
14:15 - 15:45
E-POSTER PRESENTATIONS HAEMATOLOGY - ONCOLOGY

(Screen A) e-PP53 - e-PP65

Evaluated
Evaluation

Chairmen: Eleni Bouronikou (Larissa, Greece), Georgia Kaiafa (Thessaloniki, Greece)

14:15 - 15:45
E-POSTER PRESENTATIONS INFECTIOUS DISEASES

(Screen B) e-PP66-e-PP78

Evaluated
Evaluation

Chairmen: Efthymia Giannitsioti (Athens, Greece), Periklis Panagopoulos (Alexandroupolis, Greece)

19/03 Hall CHRISALIDA
14:15 - 15:45
E-POSTER PRESENTATIONS ONCOLOGY - INFECTIOUS DISEASES - MISCELLANEOUS

(Screen C) e-PP79 - e-PP91

Evaluated
Evaluation

Chairmen: Dimitra Dimitropoulou (Patras, Greece), Maria Ioannou (Larissa, Greece)

19/03 Hall OLYMPOS
07:45 - 09:00
IMMUNOLOGY - ONCOLOGY - HAEMATOLOGY IMMUNOLOGY - ONCOLOGY - HAEMATOLOGY

OP28-OP34

Evaluated
Evaluation
07:45 - 07:55
OP28

UPDATED DATA OF A NATION-WIDE STUDY OF CLINICAL PHENOTYPES AND TACI MUTATIONS IN PATIENTS WITH COMMON VARIABLE IMMUNODEFICIENCY (CVID)

Evaluated
Evaluation

Speaker: Eirini Sevdali

07:55 - 08:05
OP29

DEFECTIVE POLYMORPHONUCLEAR NEUTROPHIL COMPARTMENT IN COMMON VARIABLE IMMUNODEFICIENCY (CVID)

Evaluated
Evaluation

Speaker: Gerasimina Tsinti

08:05 - 08:15
OP30

SECONDARY HAEMOPHAGOCYTIC SYNDROME (SHS) REVISITED: A 6-YEARS REAL-LIFE WORLD STUDY ON PRESENTATION, AETIOLOGY AND TREATMENT

Evaluated
Evaluation

Speaker: Polyxeni Lalou

08:15 - 08:25
OP31

TNF REGULATES TIGHT JUNCTION’S CLAUDIN-5 / OCCLUDIN COMPLEX MEDIATED ALVEOLAR EPITHELIAL BARRIER PERMEABILITY IN EXPERIMENTAL MURINE LUNG INJURY MODEL

Evaluated
Evaluation

Speaker: Vassiliki Karavana

08:25 - 08:35
OP32

EGFR AND KRAS GENE PROFILE IN PATIENTS WITH COLORECTAL CANCER: CORRELATION WITH CLINICOPATHOLOGICAL PARAMETERS

Evaluated
Evaluation

Speaker: Maria Samara

08:35 - 08:45
OP33

LYMPH NODE RATIO AS A PROGNOSTIC FACTOR IN GASTRIC CANCER FOLLOWING D1 GASTRECTOMY. COMPARISON WITH THE NEW TNM STAGING SYSTEM

Evaluated
Evaluation

Speaker: Konstantinos Bouliaris

08:45 - 08:55
OP34

MTHFR C677T POLYMORPHISM AND THROMBOTIC COMPLICATIONS IN GREEK SICKLE CELL DISEASE PATIENTS

Evaluated
Evaluation

Speaker: Iakovos Armenis

Chairmen: Matthaios Speletas (Larissa, Greece), Christos Tolis (Ioannina, Greece))

09:00 - 10:30
ROUND TABLE Advances in autoimmune hepatitis (AIH)

Advances in autoimmune hepatitis (AIH)

Evaluated
Evaluation
09:00 - 09:22
Advances in genetics of AIH

Evaluated
Evaluation

Speaker: Ynto de Boer (Amsterdam, The Netherlands)

09:22 - 09:44
EASL CPG guidelines on AIH

Evaluated
Evaluation

Speaker: Harald Hofer (Vienna, Austria)

09:44 - 10:06
AIH in special conditions

Evaluated
Evaluation

Speaker: Michael Heneghan (London, UK)

10:06 - 10:30
AIH in the pediatric population

Evaluated
Evaluation

Speaker: Giorgina Mieli-Vergani (London, UK)

Chairmen: Diego Vergani (London, UK), George N. Dalekos (Larissa, Greece)

10:30 - 11:00
STATE-OF-THE-ART LECTURE 

Evaluated
Evaluation
10:30 - 11:00
The role of laboratory in the diagnosis and follow-up of autoimmune liver diseases

Evaluated
Evaluation

Speaker: Diego Vergani (London, UK)

Chairmαn: George K. Koukoulis (Larissa, Greece)

11:00 - 11:30
Coffee Break 

11:30 - 13:00
ROUND TABLE 

Rheumatoid arthritis and the cardiovascular system

Evaluated
Evaluation
11:30 - 11:52
Cardiovascular disease in rheumatoid arthritis: Causes, consequences and open questions

Evaluated
Evaluation

Speaker: George D. Kitas (Dudley, UK)

11:52 - 12:14
High grade inflammation and the lipid paradox: implications for treatment

Evaluated
Evaluation

Speaker: Anne Grete Semb (Oslo, Norway)

12:14 - 12:36
Non-invasive assessment of accelerated atherosclerosis in chronic inflammatory conditions

Evaluated
Evaluation

Speaker: Athanasios Protogerou (Athens, Greece)

12:36 - 13:00
Cardiac magnetic resonance imaging in rheumatoid arthritis: promising or misleading?

Evaluated
Evaluation

Speaker: Sophie Mavrogeni (Athens, Greece)

Chairmen: George D. Kitas (Dudley, UK), Petros P. Sfikakis (Athens, Greece)

13:00 - 13:30
STATE-OF-THE-ART LECTURE STATE-OF-THE-ART LECTURE

Evaluated
Evaluation
13:00 - 13:30
Acute-on-chronic liver failure

Evaluated
Evaluation

Speaker: Rajiv Jalan (London, UK)

Chairmαn: John Koskinas (Athens, Greece)

13:30 - 14:15
SATELLITE SYMPOSIUM - Sponsored by Gilead Sciences Hellas SATELLITE SYMPOSIUM

The Role of sofosbuvir/ledipasvir in HCV cure

Evaluated
Evaluation
15:45 - 16:00
Leisure time 

16:00 - 17:30
ROUND TABLE Invasive fungal infections (IFI)

Invasive fungal infections (IFI)

Evaluated
Evaluation
16:00 - 16:22
Allogeneic hematopoietic stem cell transplantation in patients with prior invasive aspergillosis

Evaluated
Evaluation

Speaker: Nikolai Klimko (Saint Petersburg, Russia)

16:22 - 16:44
Invasive fungal infections in solid organ transplants

Evaluated
Evaluation

Speaker: Emmanuel Roilides (Thesalloniki, Greece)

16:44 - 17:06
Newer guidelines for the treatment of invasive candidiasis in nonneutropenic patients

Evaluated
Evaluation

Speaker: Sarah Georgiadou (Larissa, Greece)

17:06 - 17:30
Newer (ECIL and ESCMID/ECMM) guidelines in the treatment of IFI in leukemic patients

Evaluated
Evaluation

Speaker: Anna Skiada (Athens, Greece)

Chairmαn: George Petrikkos (Athens, Greece)

17:30 - 19:00
ROUND TABLE Inflammatory bowel disease (IBD) and the liver

Inflammatory bowel disease (IBD) and the liver

Evaluated
Evaluation
17:30 - 17:52
Management of viral hepatitis in patients with IBD

Evaluated
Evaluation

Speaker: Alessio Aghemo (Milan, Italy)

17:52 - 18:14
Primary sclerosing cholangitis

Evaluated
Evaluation

Speaker: Tom Hemming Karlsen (Oslo, Norway)

18:14 - 18:36
Liver enzyme elevations as a result from IBD therapy

Evaluated
Evaluation

Speaker: Joost P.H. Drenth (Nijmegen, The Netherlands)

18:36 - 19:00
Reasons for ALT elevation in IBD: autoimmune liver disease?

Evaluated
Evaluation

Speaker: Eric Tjwa (Nijmegen, The Netherlands)

Chairmen: Alessio Aghemo (Milan, Italy), Joost P.H. Drenth (Nijmegen, The Netherlands)

19:00 - 19:30
Coffee Break 

19:30 - 21:00
SATELLITE SYMPOSIUM - Sponsored by Bristol-Myers Squibb SATELLITE SYMPOSIUM

Evaluated
Evaluation